Published in Cochrane Database Syst Rev on January 01, 2004
Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med (2011) 3.33
Subject-ventilator synchrony during neural versus pneumatically triggered non-invasive helmet ventilation. Intensive Care Med (2008) 1.74
Utilization of mechanical ventilation for asthma exacerbations: analysis of a national database. Respir Care (2013) 1.62
Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 1.21
Use of noninvasive ventilation in patients with acute respiratory failure, 2000-2009: a population-based study. Ann Am Thorac Soc (2013) 1.17
Noninvasive positive pressure ventilation in acute respiratory failure due to COPD vs other causes: effectiveness and predictors of failure in a respiratory ICU in North India. Int J Chron Obstruct Pulmon Dis (2008) 1.10
Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: Effect of age related factors and service organisation. Thorax (2006) 1.08
Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med (2009) 1.02
Noninvasive positive-pressure ventilation in acute respiratory failure. CMAJ (2007) 0.99
Automated patient-ventilator interaction analysis during neurally adjusted non-invasive ventilation and pressure support ventilation in chronic obstructive pulmonary disease. Crit Care (2014) 0.89
Differences in care between general medicine and respiratory specialists in the management of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Thorac Med (2013) 0.87
Noninvasive ventilation in acute respiratory failure. Int J Chron Obstruct Pulmon Dis (2014) 0.86
Role of BiPAP applied through endotracheal tube in unconscious patients suffering from acute exacerbation of COPD: a pilot study. Int J Chron Obstruct Pulmon Dis (2012) 0.86
Noninvasive positive pressure ventilation for acute respiratory failure patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser (2012) 0.84
Rating the quality of trials in systematic reviews of physical therapy interventions. Cardiopulm Phys Ther J (2010) 0.83
Noninvasive ventilation in patients with chronic obstructive airway disease. Int J Chron Obstruct Pulmon Dis (2008) 0.81
Acute lung failure. Semin Respir Crit Care Med (2011) 0.81
Continuous positive airway pressure and noninvasive ventilation in prehospital treatment of patients with acute respiratory failure: a systematic review of controlled studies. Scand J Trauma Resusc Emerg Med (2014) 0.80
Noninvasive and invasive positive pressure ventilation for acute respiratory failure in critically ill patients: a comparative cohort study. J Thorac Dis (2016) 0.77
Intensive care unit admission in chronic obstructive pulmonary disease: patient information and the physician's decision-making process. Crit Care (2014) 0.77
Review: adding non-invasive positive pressure ventilation to usual care reduces treatment failure in respiratory failure. Evid Based Nurs (2005) 0.75
Comparison of exercise capacity in COPD and other etiologies of chronic respiratory failure requiring non-invasive mechanical ventilation at home: retrospective analysis of 1-year follow-up. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Home Non Invasive Ventilation (NIV) treatment for COPD patients with a history of NIV-treated exacerbation; a randomized, controlled, multi-center study. BMC Pulm Med (2016) 0.75
Update on clinical trials in home mechanical ventilation. J Thorac Dis (2016) 0.75
Evaluation of self-perception of mechanical ventilation knowledge among Brazilian final-year medical students, residents and emergency physicians. Clinics (Sao Paulo) (2017) 0.75
High flow biphasic positive airway pressure by helmet--effects on pressurization, tidal volume, carbon dioxide accumulation and noise exposure. Crit Care (2009) 0.75
Long-term non-invasive ventilation reduces readmissions in COPD patients with two or more episodes of acute hypercapnic respiratory failure. Eur Clin Respir J (2016) 0.75
Management of critical illness with non-invasive ventilation by an Australian HEMS. Emerg Med J (2016) 0.75
Inhalation therapy in mechanical ventilation. J Bras Pneumol (2015) 0.75
Prehospital treatment with continuous positive airway pressure in patients with acute respiratory failure: a regional observational study. Scand J Trauma Resusc Emerg Med (2016) 0.75
Effectiveness assessment of a guideline based protocol for ventilatory support management of COPD exacerbations in an emergency department. Braz J Phys Ther (2017) 0.75
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 10.05
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax (2002) 8.77
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax (1999) 8.63
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 5.49
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet (1993) 5.43
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 5.17
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax (2000) 4.45
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax (2002) 4.26
COPD exacerbations: definitions and classifications. Eur Respir J Suppl (2003) 3.35
COPD exacerbations .1: Epidemiology. Thorax (2006) 2.94
Arterialised earlobe blood gas analysis: an underused technique. Thorax (1994) 2.48
Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med (1995) 2.20
Respiratory medicine: fighting for survival. BMJ (1992) 2.15
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Int J Geriatr Psychiatry (2006) 2.06
Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax (2000) 2.06
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J (2007) 2.03
Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J (2000) 2.00
Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J (2006) 1.94
Relationship between depression and exacerbations in COPD. Eur Respir J (2008) 1.81
Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J (2003) 1.78
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax (1996) 1.69
Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J (2005) 1.67
Portable oxygen therapy: assessment and usage. Respir Med (1991) 1.66
Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax (1998) 1.64
Physical training for asthma. Cochrane Database Syst Rev (2005) 1.61
Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2003) 1.57
Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.56
Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J (2009) 1.52
Evaluation of pulsed dose oxygen delivery during exercise in patients with severe chronic obstructive pulmonary disease. Thorax (1999) 1.49
Using nasal intermittent positive pressure ventilation on a general respiratory ward. J R Coll Physicians Lond (1998) 1.48
An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. Respir Med (1999) 1.46
The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. Health Technol Assess (2011) 1.42
Assessment and follow up of patients prescribed long term oxygen treatment. Thorax (1993) 1.41
The effectiveness and cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation. Health Technol Assess (2010) 1.37
MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res (2005) 1.37
Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2004) 1.37
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J (2004) 1.35
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess (2006) 1.30
Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J (1999) 1.27
The heterogeneity of chronic obstructive pulmonary disease. Thorax (2000) 1.25
Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med (2000) 1.24
Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. Br Med J (Clin Res Ed) (1983) 1.23
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax (2001) 1.21
Comparison of pressure and volume preset nasal ventilator systems in stable chronic respiratory failure. Eur Respir J (1993) 1.21
Sarcoidosis presenting with stroke. Stroke (1989) 1.20
Is vitamin D deficiency important in the natural history of COPD? Thorax (2010) 1.18
Small intestinal perforation in Wegener's granulomatosis. Postgrad Med J (1982) 1.18
Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. Eur Respir J (1997) 1.17
Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J (1996) 1.11
Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J (2005) 1.10
Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report. J Clin Endocrinol Metab (2004) 1.09
Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J (2010) 1.09
Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Health Technol Assess (2007) 1.07
Nasal ventilation in acute exacerbations of chronic obstructive pulmonary disease: effect of ventilator mode on arterial blood gas tensions. Thorax (1994) 1.05
Overnight studies in severe chronic left heart failure: arrhythmias and oxygen desaturation. Br Heart J (1991) 1.04
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax (1996) 1.00
What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines. Thorax (2007) 0.98
Recent respiratory infection and the risk of myocardial infarction. Heart (2005) 0.98
Quality control of equipment in home mechanical ventilation: a European survey. Eur Respir J (2005) 0.96
Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 0.96
Nasal intermittent positive-pressure ventilation in weaning intubated patients with chronic respiratory disease from assisted intermittent, positive-pressure ventilation. Respir Med (1993) 0.95
Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion. J Thromb Haemost (2011) 0.94
Hypoxia and the heart. Br Heart J (1993) 0.94
Comparison of liquid and gaseous oxygen for domiciliary portable use. Thorax (1992) 0.93
Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking. Thorax (1996) 0.93
Recurrent neuroleptic malignant syndrome and hyponatraemia. J Neurol Neurosurg Psychiatry (1986) 0.92
Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia. Clin Sci (Lond) (1985) 0.92
Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. Eur J Cancer (2007) 0.92
Respiratory depression following morphine and morphine-6-glucuronide in normal subjects. Br J Clin Pharmacol (1995) 0.92
Neuroleptic malignant syndrome and hyponatraemia. Lancet (1984) 0.90
Chorea in digoxin toxicity. J Neurol Neurosurg Psychiatry (1984) 0.90
Reviewer selection: author or editor knows best? Thorax (2005) 0.90
An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living Scale (LCADL). Respir Med (2002) 0.90
Airway epithelial inflammatory responses and clinical parameters in COPD. Eur Respir J (2003) 0.90
Strategies for improving outcomes of COPD exacerbations. Int J Chron Obstruct Pulmon Dis (2006) 0.90
Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2003) 0.89
Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation. Postgrad Med J (2004) 0.89
Chlamydia pneumoniae and COPD exacerbation. Thorax (2002) 0.88
To publish or perish: how to review a manuscript. Rev Port Pneumol (2011) 0.88
Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Eur Respir J (2005) 0.87
Nasal masks for domiciliary positive pressure ventilation: patient usage and complications. Thorax (1994) 0.87
Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Br J Cancer (2007) 0.87
Domiciliary oxygen cylinders: indications, prescription and usage. Respir Med (1994) 0.87
Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev (2005) 0.85
Adverse effects of nasal continuous positive airway pressure therapy in sleep apnoea syndrome. J Laryngol Otol (1999) 0.85
Lapatinib for the treatment of HER2-overexpressing breast cancer. Health Technol Assess (2009) 0.85
Comparison of nasal pressure support ventilation with nasal intermittent positive pressure ventilation in patients with nocturnal hypoventilation. Eur Respir J (1993) 0.84
Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev (2005) 0.84
Molecular characterization of NOS in a mollusc: expression in a giant modulatory neuron. J Neurobiol (1998) 0.83
Ventricular arrhythmia, Cheyne-Stokes respiration, and death: observations from patients with defibrillators. Heart (2005) 0.83
Coexpressed nitric oxide synthase and apical beta(1) integrins influence tubule cell adhesion after cytokine-induced injury. J Am Soc Nephrol (2001) 0.82
Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation. Health Technol Assess (2009) 0.82
Ambulatory oxygen therapy in stable kyphoscoliosis. Eur Respir J (1995) 0.81
Chronic obstructive pulmonary disease past, present and future. Thorax (2007) 0.80